A project at RIDC CeMEAI aims to develop techniques for analyzing spatio-temporal data to identify criminal patterns and predict crime.
RIDC NeuroMat announces research opportunities related to three different research lines, each of them hosted by a specific institution in São Paulo, Ribeirão Preto and Campinas.
Study conducted by the Center for Research on Inflammatory Diseases shows that drug currently used to treat cystic fibrosis can help prevent complications from infection by SARS-CoV-2.
Synthetic compounds and molecules derived from natural products belonging to Brazil’s biodiversity are being screened by teams at the Center for Innovation in Biodiversity and Drug Discovery.
The selected candidate will work at a CeMEAI project for the development and implementation of a multiscale preconditioner in a high-performance computational environment to accelerate large scale simulations of oil reservoirs.
Higher blood glucose levels captured by defense cells provide energy for augmented viral replication, triggering overwhelming immune response that kills lung cells.
Scientists affiliated with RIDC CRID set out to understand the strategies used by immune cells to combat the most severe phase of the disease.
Strategy would maintain economic activity and protect healthcare services, according to system developed by RIDC CeMEAI.
Only 1.2% of population of largest city in north of São Paulo State have been infected by SARS-CoV-2
Estimate is based on testing of 700 inhabitants of Ribeirão Preto in early May. Another round of testing will be conducted in June. The study is carried out by the University of São Paulo in partnership with the city’s health department
Scientists associated with the RIDC OCRC are the only Latin American group to have had a project selected in an international request for applications by the CZI. More than USD 175,000 has been awarded to the study, which will be the first in Brazil to use single-cell analysis.